...
首页> 外文期刊>Nephron >Dialyzers Designed to Increase Internal Filtration Do Not Result in Significantly Increased Platelet Activation and Thrombin Generation
【24h】

Dialyzers Designed to Increase Internal Filtration Do Not Result in Significantly Increased Platelet Activation and Thrombin Generation

机译:设计用于增加内部过滤的透析器不会导致血小板活化和凝血酶生成显着增加

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

lntroduction:To increase middle molecule clearances, high-flux dialyzers with increased internal filtration have been developed. However, dialyzer design and structure may affect thrombin generation and platelet activation, thereby risking increased clotting and reduced dialyzer clearances. Methods: Coagulation parameters, platelet, white cell and endo-thelial activation markers were measured prior to and following dialysis sessions in 12 patients using two different dialyzers designed for increased internal filtration. Results: Prior to dialysis, patients had evidence of activation of coagulation with increased factor VllI:hC, thrombin-antithrom-bin complexes and prothrombin fragment 1+2, increased platelet activation, with raised platelet factor 4, beta-thrombo-globulin levels and increased fibrinolysis (raised D-dimers). Dialysis was associated with the release of soluble platelet integrin, sP selectin, increased endothelial activation with increased levels of von Willebrand factor (vWF) antigen (vWF:Ag) and vWF propeptide (vWF:pp) and sE selectin. There was no difference in tinzaparin levels at the end of the dialysis session using either dialyzer, as shown by anti-Xa activity - 0.145 +- 0.027 versus 0.11 +- 0.017 IU/ml, respectively.
机译:简介:为了增加中间分子的清除率,已开发出具有内部过滤功能增强的高通量透析器。但是,透析器的设计和结构可能会影响凝血酶的产生和血小板活化,从而有增加凝结和降低透析器清除率的风险。方法:使用两个设计用于增加内部过滤的透析器,对12例患者在透析前后的凝血参数,血小板,白细胞和内皮激活标记进行了测量。结果:透析前,患者有凝血因子VII,hC,凝血酶-抗凝血酶-复合物和凝血酶原片段1 + 2增加,血小板活化增加,血小板因子4,β-血栓球蛋白水平升高和凝血激活的证据。纤维蛋白溶解增加(D-二聚体升高)。透析与可溶性血小板整联蛋白,sP选择素的释放,内皮细胞激活的增加以及von Willebrand因子(vWF)抗原(vWF:Ag)和vWF前肽(vWF:pp)和sE选择素水平的升高有关。如使用抗Xa活性分别为0.145 +-0.027和0.11 +-0.017 IU / ml,使用两种透析器进行的透析过程结束时,tinzaparin水平没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号